Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 Late-Season Earnings Plays for Mid-Cap Traders: https://www.marketbeat.com/logos/articles/med_20230531075618_3-late-season-earnings-plays-for-mid-cap-traders.jpg
3 Late-Season Earnings Plays for Mid-Cap Traders

As June rolls around, amusement parks and beachside cabanas are getting worked into the budgets of vacation-hungry Americans. For U.S. stock traders, summer’s kickoff coincides with the conclusion

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery
Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

-          An innovative covalent platform for precision targeting of disease-causing proteins

 

-          Seed financing led by RA Capital Management, Droia Ventures, and Novartis Venture

KB Home Constructs Bullish Price Action As Wider Industry Thrives
KB Home Constructs Bullish Price Action As Wider Industry Thrives

Key Points

  • High interest rates are keeping homeowners in place, boosting homebuilders’ stocks.
  • KB Home, a Los Angeles-based midcap, shows potential for further gains as it consolidates in a